IDDF2021-ABS-0192 The role cytomegalovirus detection in active inflammatory bowel disease
BackgroundIt is known that Cytomegalovirus (CMV) can be detected in the colon during active Inflammatory Bowel Disease (IBD). However, its pathogenic role in causing active inflammation remains unclear as this ubiquitous virus is also regarded as innocent bystander. We aim to examine the utility of...
Gespeichert in:
Veröffentlicht in: | Gut 2021-09, Vol.70 (Suppl 2), p.A143-A143 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | BackgroundIt is known that Cytomegalovirus (CMV) can be detected in the colon during active Inflammatory Bowel Disease (IBD). However, its pathogenic role in causing active inflammation remains unclear as this ubiquitous virus is also regarded as innocent bystander. We aim to examine the utility of CMV testing in the colonic specimen and correlate with clinical outcome.MethodsA retrospective review of IBD patients with active symptomatic disease undergoing colonoscopy in National University Hospital Singapore from 2012-2020 and CMV tissue studies (histology with CMV Immunohistochemistry (IHC), CMV polymerase chain reaction (PCR), and tissue CMV culture) was conducted. The electronic medical record was analysed for clinical outcomes and CMV treatment.ResultsOf 492 patients under IBD clinic follow up, 91 patients with active disease (42 Crohn’s Disease, 44 Ulcerative Colitis, 5 Unclassified IBD) underwent colonoscopy and CMV tissue studies. The mean age is 40.13±15.24 years with 54 males and 37 females. CMV tissue studies were positive in 20 (28.8%) patients. A large majority of these patients (14/20; 70%) achieved steroid-free remission without CMV treatment which suggests that CMV is innocent bystander. However, the rest (6 patients) had worsening or protracted active disease and were treated with a course of valganciclovir or ganciclovir which resulted in remission in all 6 patients, suggesting that CMV contributed to active disease activity.We compared different testing modalities among those 20 patients with positive CMV and correlated with disease course. Refractory disease occurred in 2/3 (66.6%) IHC positive patients and 3/5 (60.0%) patients with positivity of both IHC and CMV PCR, as compared to only 1/11 (9.1%) patients with positive CMV PCR, and none (0/1) in patients with positive CMV culture.ConclusionsColonic CMV was detected in 28.8% of patients with active IBD, but the large majority does not need CMV treatment. Positive IHC was associated with refractory disease as compared to PCR and CMV cultures. |
---|---|
ISSN: | 0017-5749 1468-3288 |
DOI: | 10.1136/gutjnl-2021-IDDF.173 |